Celularity (CELU) Stock Statistics & Valuation Metrics

Celularity has a market cap or net worth of $23.40M. The enterprise value is $54.17M.

Celularity has 28,945,961 shares outstanding. The number of shares has decreased by -2.65% in one year.

Celularity’s return on equity (ROE) is 2.41 and return on invested capital (ROIC) is -151.11%.

The current PE Ratio of Celularity is ―. Celularity’s PEG ratio is -0.00866.

In the last 12 months, Celularity had revenue of 26.55M and earned -91.80M in profits. Earnings per share was -3.59.

In the last 12 months, operating cash flow was -13.25M and capital expenditures 0.00, giving a free cash flow of -13.25M billion.

Celularity pays an annual dividend of ―, resulting in a dividend yield of ―

Celularity upcoming earnings date is Apr 1, 2027, After Close (Confirmed).

Celularity as a current ratio of 0.15, with Debt / Equity ratio of -107.46%

In the past 12 months, Celularity has paid 3.00K in taxes.

Celularity EV to EBITDA ratio is -0.81, with an EV/FCF ratio of -4.76.

Celularity has $6.17M in cash and marketable securities with $40.90M in debt, giving a net cash position of -$34.73M billion.

Gross margin is 76.04%, with operating margin of -230.92%, and net profit margin of -345.76%.

The average price target for Celularity is ―, which is 11.43% higher than the current price. The consensus rating is ―